Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
SiliconANGLEen
Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract research organization in the U.S. to supply biotech and pharmaceutical companies with the molecules their […] The post Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry appeared first on SiliconANGLE .
This is a short summary published by AI Global Wire. The full article is owned and hosted by SiliconANGLE — open it there to read it in full.
Read the full story at SiliconANGLE- OpenAI
- Verktyg
- Forskning
- Företag
Related AI news
- Agentic AI Foundation adds four more open-source AI toolsSiliconANGLE · October 22, 2026
- Mave raises $34M to pull existing security tools into one agentic systemSiliconANGLE · October 22, 2026
- Sources: OpenAI has cut its valuation target to $1.25T, down from the $1.4T valuation it pitched earlier this month, after facing resistance from some investors (Financial Times)Techmeme · October 22, 2026
- What to expect during EVOLVE26: Join theCUBE on Oct. 27SiliconANGLE · October 22, 2026
- OpenAI working on new $30B raise at $1.25T valuation ahead of IPOTechCrunch AI · October 22, 2026
- Canva’s first AI image model plans designs before generating themThe Verge AI · October 22, 2026